Skip to main content
SpringerLink
Log in

Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs

  • Conference paper
Tumor Prevention and Genetics

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 163))

Abstract

The mouse skin model of multistage carcinogenesis has demonstrated that cancer results from a synergism between genotoxic and nongenotoxic factors. The former induce irreversible genetic alterations, whereas the latter promote tumor development by favoring the clonal outgrowth of the genetically altered cells. While therapeutic gene repair is a still unrealized dream, tumor promotion provides an attractive target for cancer prevention. Akey event in epithelial tumor development is an aberrant constitutive overexpression of cyclooxygenase-2 (COX-2), being detectable already in premalignant lesions and leading to an overproduction of prostaglandins. In the mouse skin model, prostaglandin F2α has been identified as an endogenous tumor promoter. The well-established chemopreventive effect of nonsteroidal anti-inflammatory drugs seems to be mainly due to COX-2 inhibition. Targeted transgenic overexpression of COX-2 in mouse epidermis induces a preneoplastic phenotype and renders the tissue extremely sensitive to genotoxic carcinogens; i.e., for the induction of skin tumor development, tumor promoter treatment can be omitted in those animals. It is concluded that COX-2 acts as an endogenous tumor promoter and that its overexpression represents a first order risk factor for cancer development. Conversely, specific COX-2 inhibitors rank among the most promising agents for cancer chemoprevention.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Buckman SY, Gresham A, Hale P, et al (1998) COX-2 expression is induced by UVB exposure in human skin: implication for the development of skin cancer. Carcinogenesis 19:723–729

    Article  PubMed  CAS  Google Scholar 

  • Chan G, Boyle JO, Yang EK, et al (1999) Cyclooxygenase-2 expression is upregulated in squamous cell carcinoma of the head and the neck. Cancer Res 59:991–994

    PubMed  CAS  Google Scholar 

  • Chariyalertsak S, Sirikulchajanonta V, Mayer D, et al (2001) Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma. Gut 48:80–86

    Article  PubMed  CAS  Google Scholar 

  • DiGiovanni J (1992) Multistage carcinogenesis in mouse skin. Pharmacol Ther 54:63–128

    Article  PubMed  CAS  Google Scholar 

  • Fischer SM, Lo HH, Gordon GB, et al (1999) Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 25:231–240

    Article  PubMed  CAS  Google Scholar 

  • Fürstenberger G, Gross M, Marks F (1989) Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion). Carcinogenesis 10:91–96

    Article  PubMed  Google Scholar 

  • Giardiello F, Hamilton SR, Krush AJ, et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316

    Article  PubMed  CAS  Google Scholar 

  • Grubbs CJ, Lubet RA, Koki AT, et al (2000) Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer 344 rats. Cancer Res 60:5599–5602

    PubMed  CAS  Google Scholar 

  • Gupta RA, DuBois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nature Rev Cancer 1:11–21

    Article  CAS  Google Scholar 

  • Hanif R, Pittas A, Feng Y, et al (1996) Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by prostaglandin-independent pathway. Biochem Pharmacol 62:237–246

    Article  Google Scholar 

  • Hao Y, Bishop AE, Wallace M, et al (1999) Early expression of cyclooxygenase-2 during sporadic colorectal carcinogenesis. J Pathol 187:295–301

    Article  PubMed  CAS  Google Scholar 

  • Harris RE, Alshafie GA, Abov-Issa H, et al (2000) Chemoprevention of breast cancer in rats by Celecoxib, a cyclooxygenase-2 inhibitor. Cancer Res 60:2101–2103

    PubMed  CAS  Google Scholar 

  • Hendel J, Nielsen OH (1997) Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol 92:1170–1173

    PubMed  CAS  Google Scholar 

  • Howe LR, Crawford HC, Subbaramaiah K, et al (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 276:20108–20115

    Article  PubMed  CAS  Google Scholar 

  • Huang C, Ma WY, Hahnenberger D, Cleary MP, Bowden GT, Dong Z (1997) Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J Chem 272:26325–26331

    CAS  Google Scholar 

  • Hwang D, Scollard D, Byrne J, et al (1998) Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 90:455–460

    Article  PubMed  CAS  Google Scholar 

  • Jacoby RF, Seibert K, Cole CE, et al (2000) The cyclooxygenase-2 inhibitor Celecoxib is a potent preventive and therapeutic agent in the Min mouse model of adenomatous polyposis. Cancer Res 60:5040–5044

    PubMed  CAS  Google Scholar 

  • Jänne PA, Mayer RJ (2000) Chemoprevention of colorectal cancer. New Engl J Med 342:1960–1968

    Article  PubMed  Google Scholar 

  • Kawamori T, Rao CV, Seibert K, et al (1998) Chemopreventive activity of Celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis. Cancer Res 58:409–412

    PubMed  CAS  Google Scholar 

  • Koga H, Sakisaka S, Ohishi M, et al (1999) Expression of cyclooxygenase-2 in hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology 29:688–696

    Article  PubMed  CAS  Google Scholar 

  • Kulkarni S, Rader JS, Zhang F, et al (2001) Cyclooxygenase-2 is overexpressed in human cervical cancer. Clin Cancer Res 7:429–434

    PubMed  CAS  Google Scholar 

  • Langenbach R, Loftin C, Lee C, et al (1999) Cyclooxygenase knockout mice. Biochem Pharmacol 58: 1237–1246

    Article  CAS  Google Scholar 

  • Lehman JM, Lenhard JM, Oliver BB, et al (1997) Peroxisome proliferator-activated receptors α and Γ are activated by indomethacin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 272:3406–3410

    Article  Google Scholar 

  • Liu CH, Chang SH, Narko K, et al (2001) Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 276:18563–18569

    Article  PubMed  CAS  Google Scholar 

  • Marks F (1999) Arachidonic acid and companions: an abundant source of biological signals. In: Marks F, Fürstenberger G (eds) Prostaglandins, leukotrienes, and other eicosanoids: Wiley-VCH, Weinheim, pp 1–46

    Chapter  Google Scholar 

  • Marks F. (2001) Krebs-und Alzheirner-Pravention mit nicht-steroidalen Entziindungshemmern. Dtsch Med Wschr 126:308–313

    Article  PubMed  CAS  Google Scholar 

  • Marks F, Fürstenberger G (2000) Cancer chemoprevention through interruption of multistage carcinogenesis: the lessons learnt by comparing mouse skin carcinogenesis and human large bowel cancer. Eur J Cancer 36:314–29

    Article  PubMed  CAS  Google Scholar 

  • Marks F, Fürstenberger G (1999) Eicosanoids and cancer. In: Marks F, Fürstenberger G (eds) Prostaglandins, leukotrienes, and other eicosanoids. Wiley-VCH, Weinheim, pp 303–330

    Chapter  Google Scholar 

  • Marks F, Fürstenberger G (1995) Tumor promotion in skin. In: Arcos CE, Arcos MF, Woo YT (eds) Chemical induction of cancer. Birkhauser, Boston, pp 125–160

    Chapter  Google Scholar 

  • Marks F, Fürstenberger G, Müller-Decker K (1999) Metabolic targets of cancer chemoprevention: interruption of tumor development by inhibitors of arachidonic acid metabolism. In: Senn JH, Costa A, Jordan VC (eds) Chemoprevention of cancer. Springer, Berlin, pp 45–67

    Chapter  Google Scholar 

  • Marnett LJ, Kalgutkar AS (1999) Cyclooxygenase-2 inhibitors: discovery, selectivity and the future. Trends Pharmacol Sci 20:465–469

    Article  PubMed  CAS  Google Scholar 

  • Masferrer JL, Leahy KM, Koki AT, et al (2000) Anti-angiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res 60:1306–1311

    PubMed  CAS  Google Scholar 

  • Müller-Decker K (1999) Cyclooxygenases. In: Marks F, Fürstenberger G (eds) Prostaglandins, leukotrienes and other eicosanoids. VCH-Wiley, Weinheim pp 65–88

    Chapter  Google Scholar 

  • Müller-Decker K, Scholz K, Marks F, et al (1995) Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog 12:31–41

    Article  PubMed  Google Scholar 

  • Müller-Decker K, Kopp-Schneider A, Marks F, et al (1998) Localization of prostaglandin H synthase isozymes in murine epidermal tumors: suppression of skin tumor promotion by PGHS-2 inhibition. Mol Carcinog 23:36–44

    Article  PubMed  Google Scholar 

  • Müller-Decker K, Reinerth G, Krieg P, et al (1999a) Expression of prostaglandin-H synthase isozymes in normal human skin and epidermal neoplasias. Int J Cancer 80:648–656

    Article  Google Scholar 

  • Müller-Decker K, Albert C, Lukanov T, et al (1999b) Cellular localization of cyclooxygenase isozymes in Crohn’ s disease and colorectal cancer. Int J Colorectal Dis 14:212–218

    Article  PubMed  Google Scholar 

  • Müller-Decker K, Hirschner W, Marks F, et al (2002a) The effects of cyclooxygenase isozyme inhibition on incisional wound healing in mouse skin. J Invest DermatoI 119:1189–1195

    Article  Google Scholar 

  • Müller-Decker K, Neufang G, Berger I, et al (2002b) Transgenic cyclooxygenase-2 overexpression sensitizes mouse skin for carcinogenesis. Proc Natl Acad Sci USA 99:12483–12488

    Article  PubMed  Google Scholar 

  • Mutoh M, Watanabe K, Kitamura T, et al (2002) Involvement of prostaglandin E receptor subtype EP(4) in colon carcinogenesis. Cancer Res 62:28–32

    PubMed  CAS  Google Scholar 

  • Narumiya S, Sugimoto J, Ushikubi F (1999) Prostanoid receptors: structures, properties, and function. Pharmacol Rev 79:1193–1226.

    CAS  Google Scholar 

  • Neufang G, Fürstenberger G, Heidt M, et al (2001) Abnormal differentiation of epidermis in transgenic mice const itutively express ing cyclooxygenase-2 in skin. Proc Natl Acad Sci USA 98:7629–7634

    Article  PubMed  CAS  Google Scholar 

  • Nishimura G, Yanoma S, Mizuno H, et al (1999) A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells. Ipn J Cancer Res 90:1152–1162

    Article  CAS  Google Scholar 

  • Oshima M, Dinchuk JE, Kargman SL, et al (1996) Suppression of intestinal polyposis in APCδ716 knockout mice by inhibition of cydooxygenase-2 (COX-2). Cell 67:803–809

    Article  Google Scholar 

  • Oshima M, Murai N, Kargman S, et al (2001) Chemoprevention of intestinal polyposis in the APCΔ716 mouse by Rofecoxib, a specific cydooxygenase-2 inhibitor. Cancer Res 61:17331740

    Google Scholar 

  • Pentland AP, Schoggins JW, Scott GA, et al (1999) Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition. Carcinogenesis 20:1939–1944

    Article  PubMed  CAS  Google Scholar 

  • Poon R, Smits R, Li C, et al (2001) Cydooxygenase-2 modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene 20:451–460

    Article  PubMed  CAS  Google Scholar 

  • Ratnasinghe D, Tanrea J, Roth MJ, et al (1999) Expression of cydooxygenase-2 in human squamous cell carcinoma of the esophagus: an immunohistochemical study. Anticancer Res 19:171–174

    PubMed  CAS  Google Scholar 

  • Reddy BS, Hirose Y, Lubet R, et al (2000) Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, Celecoxib, administered during different stages of carcinogenesis. Cancer Res 60:293–297

    PubMed  CAS  Google Scholar 

  • Rigas B, Shiff SJ (2000) Is inhibition of cycloxygenase required for the chemopreventive effect ofNSAIDs in colon cancer? A model reconciling the current contradiction. Med Hypotheses 54:210–215

    Article  PubMed  CAS  Google Scholar 

  • Ristimäki A, Honkanen N, Jankälä H, et al (1997) Expression of cyclooxygenase-2 in human gastric carcinoma. Cancer Res 57:1270–1280

    Google Scholar 

  • Ristimäki A, Nieminen O, Saukkonen K, et al (2001) Expression of cydooxygenase-2 in human transitional cell carcinoma of the urinary bladder. Am J Pathol 158:849–853

    Article  PubMed  Google Scholar 

  • Rivers JK, Arlette J, Shear N, et al (2002) Topical treatment of actinic keratoses with 3.0% didofenac in 2.5% hyaluronan gel. Brit J Dermatol 146:1–7

    Article  Google Scholar 

  • Sawaoka H, Kawano S, Tsujii S, et al (1998) Helicobacter pylori infection induces cyclooxygenase-2 expression in human gastric mucosa. Prostaglandins Leukot Essent Fatty Acids 59:313–316

    Article  PubMed  CAS  Google Scholar 

  • Scholz K, Fürstenberger G, Müller-Decker K, et al (1995) Differential expression of pros taglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biochem J 309:263–269

    PubMed  CAS  Google Scholar 

  • Schwenger P, Alpert D, Skolnik EY, et al (1998) Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IkappaB alpha phosphorylation and degradation. Mol Cell Biol 18:78–84

    PubMed  CAS  Google Scholar 

  • Schwenger P, Bellosta P, Victor I, et al (1997) Sodium salicylate inhibits apoptos is via p38 mitogene-activated protein kinase but inhib its TNFα-induced clun N-term inal kinase/stress-activated protein kinase activation. Proc Natl Acad Sci 94:2869–2873

    Article  PubMed  CAS  Google Scholar 

  • Sharpe CR, Collet l-P, McNurr M, et al (2000) Nested case-control study of the effects of nonsteroidal anti-inflammatory drugs on breast cancer risk and stage. Br J Cancer 83:112–120

    Article  PubMed  CAS  Google Scholar 

  • Shiota G, Okubo M, Noumi T, et al (1999) Cyclooxygenase-2 expression in hepato-cellular carcinoma. Hepatogastroenterology 46:407–412

    PubMed  CAS  Google Scholar 

  • Shiotani H, Denda A, Yamamota K, et al (2001) Increased expression of cyclooxygenase-2 protein in 4-nitroquinoline-l-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, Nimesulide. Cancer Res 61:1451–1456

    PubMed  CAS  Google Scholar 

  • Shono T, Tofilon PJ, Bruner JM, et al (2001) Cydooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61:4375–4381

    PubMed  CAS  Google Scholar 

  • Shureiqi I, Lippman SM (2001) Lipoxygenase modulation to reverse carcinogenesis. Cancer Res 61:6307–6312

    PubMed  CAS  Google Scholar 

  • Singer II, Kawka DW, Schloemann S, et al (1999) Cydooxygenase-2 is induced in colonic epithelial cells in inflammatory bowel disease. Gastroenterology 115:297–306

    Article  Google Scholar 

  • Smalley WE, DuBois RN (1997) Colorectal cancer and nonsteroidal anti-inflammatory drugs. Adv PharmacoI 39:1–20

    Article  CAS  Google Scholar 

  • Sonoshita, M, Takaku K, Sasaki N, et al (2001) Acceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice. Nature Med 9:1048–1051

    Google Scholar 

  • Steinbach G, Lynch PM, Phillips RKS, et al (2000) The effect of Celecoxib, a cyelooxygenase-2 inhibitor, in familial adenomatous polyposis. New Engl J Med 342:1946–1952

    Article  PubMed  CAS  Google Scholar 

  • Tegeder I, Pfeilschifter J, Geisslinger G (2001) Cyelooxygenase-independent actions of cyelooxygenase inhibitors. FASEB J 15:2057–2072

    Article  PubMed  CAS  Google Scholar 

  • Tiano HF, Chulada PC, Spalding J, et al (1998) Effects of cyelooxygenase deficiency on inflammation and papilloma formation in mouse skin. Proc Am Assoc Cancer Res 38:253

    Google Scholar 

  • Tiano HF, Loftin CD, Akunda J, et al (2002) Deficiency of either cyelooxygenase COX-l or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis. Cancer Res 62:3395–3401

    PubMed  CAS  Google Scholar 

  • Tsuji S, Tsujii M, Kawano S, et al (2001) Cyelooxygenase-2 upregulation as a perigenetic change in carcinogenesis. J Exp Clin Cancer Res 20:117–129

    PubMed  CAS  Google Scholar 

  • Tucker ON, Dannenberg AJ, Yang EK, et al (1999) Cyelooxygenase expression is up-regulated in human pancreatic cancer. Cancer Res 59:987–990

    PubMed  CAS  Google Scholar 

  • Vane JR, Bakhle YS (1998) Botting RM Cyeloxygenase 1 and 2. Annu Rev Pharmacol Toxicol 38:97–120

    Article  PubMed  CAS  Google Scholar 

  • Watanabe K, Kawamori T, Nakatsugi S, et al (1999) Role of the prostaglandin E receptor subtype EPI in colon carcinogenesis. Cancer Res 59:5093–5096

    PubMed  CAS  Google Scholar 

  • Watanabe K, Kawamori T, Nakatsugi S, et al (2000) Inhibitory effect of a prostaglandin E receptor subtype El selective antagonist. ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice. Cancer Lett 156:57–61

    Article  PubMed  CAS  Google Scholar 

  • Watkins DN, Lenzo JC, Segal A, et al (1999) Expression and localization of cyelo-oxygenase isoforms in nons mall cell lung cancer. Eur Respir J 11:412–418

    Article  Google Scholar 

  • Williams GS, Watson AJ, Sheng H, et al (2000) Celecoxib prevents tumor growth in vivo without toxicity to normal gut: lack of correlation between in vitro and in vivo models. Cancer Res 60:8045–8051

    Google Scholar 

  • Wilson KT, Fu S, Ramanujam KS, et al (1998) Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett’s esophagus and associated adenocarcinomas. Cancer Res 58:2929–2934

    PubMed  CAS  Google Scholar 

  • Winde G, Schmid KW, Brandt B, et al (1997) Clinical and genomic influence of sulindac on retal mucosa in familial adenomatous polyposis. Dis Colon Rectum 40:1156–1169

    Article  PubMed  CAS  Google Scholar 

  • Wolff H, Saukonen K, Anttila S, et al (1998) Expression of cyelooxygenase-2 in human lung carcinoma. Cancer Res 58:4997–5001

    PubMed  CAS  Google Scholar 

  • Yin MY, Yamamoto Y, Gaynor RB (1998) The anti-inflammatory agents aspirin and salicylate inhibit the activity of! kappa Bkinase-beta. Nature 396:77–80

    Article  PubMed  CAS  Google Scholar 

  • Yoshimura R, Sano H, Masuda C, et al (2000) Expression of cyelooxygenase-2 in prostate carcinoma. Cancer 89:589–596

    Article  PubMed  CAS  Google Scholar 

  • Zhang F, Subbaramaiah K, Altorki N, Dannenberg AJ (1998) Dihydroxy bile acids activate the transcription of cyelooxygenase-2. J Biol Chem 273:2424–2436

    Article  PubMed  CAS  Google Scholar 

  • Zhang X, Morham SG, Langenbach R, Young DA (1999) Malignant transformation and antineoplastic actions of nonsteroidal antiinflammatory drugs (NSAIDs) on cyelooxygenasenull embryo fibroblasts. J Exp Med 190:451–459

    Article  PubMed  CAS  Google Scholar 

  • Zhang X, Morham SG, Langenbach R, et al (2000) Lack of cyelooxygenase-2 inhibits growth of teratocarcinomas in mice. Exp Cell Res 254:232–240

    Article  PubMed  CAS  Google Scholar 

  • Zimmermann KC, Sarbi M, Weber AA et al (1999) Cyelooxygenase-2 expression in human esophageal carcinoma. Cancer Res 59:198–204

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Program Tumor Cell Regulation, Deutsches Krebsforschungszentrum (DKFZ), 69120, Heidelberg, Germany

    Friedrich Marks, Gerhard Fürstenberger, Gitta Neufang & Karin Müller-Decker

Authors
  1. Friedrich Marks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gerhard Fürstenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gitta Neufang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Karin Müller-Decker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Zentrum für Tumordiagnostik und Prävention, Rorschacherstr. 150, 9006, St. Gallen, Switzerland

    Hans-Jörg Senn  & Rudolf Morant  & 

Rights and permissions

Reprints and permissions

Copyright information

© 2003 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Marks, F., Fürstenberger, G., Neufang, G., Müller-Decker, K. (2003). Mouse Skin as a Model for Cancer Chemoprevention by Nonsteroidal Anti-Inflammatory Drugs. In: Senn, HJ., Morant, R. (eds) Tumor Prevention and Genetics. Recent Results in Cancer Research, vol 163. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55647-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55647-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62892-4

  • Online ISBN: 978-3-642-55647-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation